Captrust Financial Advisors Novartis Ag Transaction History

Captrust Financial Advisors

  • $30.9 Billion
  • Q2 2024

A detailed history of Captrust Financial Advisors transactions in Novartis Ag stock. As of the latest transaction made, Captrust Financial Advisors holds 129,315 shares of NVS stock, worth $15 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
129,315
Previous 126,781 2.0%
Holding current value
$15 Million
Previous $12.3 Million 12.26%
% of portfolio
0.04%
Previous 0.04%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$92.57 - $107.37 $234,572 - $272,075
2,534 Added 2.0%
129,315 $13.8 Million
Q1 2024

May 15, 2024
SELL
$95.27 - $108.47 $1.37 Million - $1.56 Million
-14,338 Reduced 10.16%
126,781 $12.3 Million
Q4 2023

Feb 14, 2024
BUY
$92.27 - $101.54 $68,925 - $75,850
747 Added 0.53%
141,119 $14.2 Million
Q3 2023

Nov 14, 2023
BUY
$94.73 - $105.13 $1.03 Million - $1.14 Million
10,829 Added 8.36%
140,372 $14.3 Million
Q2 2023

Aug 14, 2023
BUY
$92.52 - $104.91 $1.41 Million - $1.59 Million
15,196 Added 13.29%
129,543 $13.1 Million
Q1 2023

May 15, 2023
BUY
$80.03 - $92.81 $342,928 - $397,690
4,285 Added 3.89%
114,347 $10.5 Million
Q4 2022

Feb 15, 2023
SELL
$75.55 - $92.52 $56,209 - $68,834
-744 Reduced 0.67%
110,062 $9.98 Million
Q3 2022

Nov 16, 2022
BUY
$74.61 - $87.26 $1.11 Million - $1.3 Million
14,877 Added 15.51%
110,806 $8.42 Million
Q2 2022

Aug 23, 2022
SELL
$80.52 - $93.75 $612,435 - $713,062
-7,606 Reduced 7.35%
95,929 $8.11 Million
Q2 2022

Aug 16, 2022
BUY
$80.52 - $93.75 $1.37 Million - $1.6 Million
17,016 Added 19.67%
103,535 $8.75 Million
Q1 2022

May 16, 2022
BUY
$80.11 - $90.62 $131,780 - $149,069
1,645 Added 1.94%
86,519 $7.59 Million
Q4 2021

Feb 14, 2022
BUY
$79.7 - $88.13 $157,407 - $174,056
1,975 Added 2.38%
84,874 $7.42 Million
Q3 2021

Nov 16, 2021
BUY
$81.78 - $95.14 $368,418 - $428,605
4,505 Added 5.75%
82,899 $6.78 Million
Q2 2021

Aug 16, 2021
SELL
$85.24 - $94.15 $229,380 - $253,357
-2,691 Reduced 3.32%
78,394 $7.15 Million
Q1 2021

May 17, 2021
BUY
$83.5 - $98.47 $280,727 - $331,056
3,362 Added 4.33%
81,085 $6.93 Million
Q4 2020

Feb 16, 2021
BUY
$78.07 - $94.43 $176,360 - $213,317
2,259 Added 2.99%
77,723 $7.34 Million
Q3 2020

Nov 17, 2020
SELL
$82.14 - $91.0 $77,868 - $86,268
-948 Reduced 1.24%
75,464 $6.59 Million
Q2 2020

Aug 14, 2020
BUY
$80.93 - $91.1 $279,613 - $314,750
3,455 Added 4.74%
76,412 $6.71 Million
Q1 2020

May 15, 2020
BUY
$70.67 - $99.01 $28,974 - $40,594
410 Added 0.57%
72,957 $5.9 Million
Q4 2019

Feb 14, 2020
BUY
$84.35 - $95.37 $6.12 Million - $6.92 Million
72,547 New
72,547 $6.89 Million

Others Institutions Holding NVS

# of Institutions
1,426
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.54M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $249B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email